Bone implant and systems that controllably releases silver
Silver and/or zinc ion releasing implants, systems and method of operating, inserting and activating/inactivating them are described. In some variations the implant is configured as a bone implant that includes a bone-screw or intramedullary rod like body configured to receive a treatment cartridge having a plurality of ion-releasing members configured as an anode that can controllably engage with a catheter to turn galvanic release of ions on/off as desired. These devices may be configured to release silver ions (and/or zinc ions) above a predetermined level for a predetermined period of time and may maintain a concentration of ions over a relatively large volume of tissue. The ion-releasing members may be configured to reduce or prevent implant movement.
1. An implant for providing antimicrobial treatment to a bone, tissue or organ, the implant comprising:
an elongate body having a threaded outer screw region;
an inner channel within the elongate body;
a plurality of exit channels extending from the inner channel and out through the threaded outer screw region; and
a treatment cartridge, the treatment cartridge including a cartridge body configured to fit within and mate with the inner channel and a plurality of silver, zinc, or silver and zinc release members, each release member configured to extend from the cartridge body out through an exit channel.
2. The implant of claim 1 wherein a cross-sectional area of the inner channel comprises a non-circular shape.
3. The implant of claim 1 , wherein the exit channels are configured to deflect the release members against the outer threaded region so that they deflect away from the implant.
4. The implant of claim 1 , wherein the plurality of release members of the treatment cartridge are anodes; further wherein the threaded outer screw region comprises a metal cathode having a higher galvanic potential than the anodes so as to drive the galvanic release of silver, zinc, or silver and zinc from the release members.
5. The implant of claim 4 , wherein the cathode comprises an irregular surface.
6. The implant of claim 1 , wherein the treatment cartridge is configured to be removably connected in situ in the inner channel of the elongate body.
7. The implant of claim 1 , wherein the release members comprises one or more flexible wires.
8. The implant of claim 1 , wherein the treatment cartridge comprises a sampler element configured to obtain a sample from a patient in whom the implant has been implanted.
9. The implant of claim 1 , wherein the elongate body comprises a material selected from the group consisting of palladium, platinum, and gold.
10. The implant of claim 1 , wherein the treatment cartridge is configured to degrade within the body.
11. An implant for providing antimicrobial treatment to a bone, tissue or organ, the implant comprising:
an elongate body having a threaded screw region;
an inner channel within the elongate body;
a plurality of exit channels extending from the inner channel and out through the threaded screw region; and
a treatment cartridge, the treatment cartridge including a cartridge body configured to mate with the inner channel, and a plurality of silver, zinc, or silver and zinc release members, each release member configured to extend from the cartridge body out through an exit channel;
wherein the plurality of release members of the treatment cartridge are anodes, further wherein the threaded screw region comprises a comprises a metal cathode selected from the group consisting of palladium, platinum, and gold so as to drive the galvanic release of silver, zinc, or silver and zinc from the release members.
12. The implant of claim 11 , wherein a cross-sectional area of the inner channel comprises a non-circular shape.
13. The implant of claim 11 , wherein the exit channels are configured to deflect the release members against the threaded region so that they deflect away from the implant.
14. The implant of claim 11 , wherein the cathode comprises an irregular surface.
15. The implant of claim 11 , wherein the treatment cartridge is configured to be removably connected in situ in the inner channel of the elongate body.
16. The implant of claim 11 , wherein the release members comprises one or more flexible wires.
17. The implant of claim 11 , wherein the treatment cartridge comprises a sampler element configured to obtain a sample from a patient in whom the implant has been implanted.
18. The implant of claim 11 , wherein the treatment cartridge is configured to degrade within the body.